Literature DB >> 8848272

Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.

M C Sañudo-Peña1, S L Patrick, R L Patrick, J M Walker.   

Abstract

The effect of unilateral intranigral cannabinoid receptor stimulation on rotational behavior was explored. The potent cannabinoid agonist CP 55,940 (5 and 10 micrograms/0.5 microliter) induced contralateral turning when microinjected unilaterally into the substantia nigra pars reticulata. In addition, the cannabinoid agonist markedly attenuated the contralateral rotation induced by the dopamine D1 agonist SKF 82958 and completely reversed the ipsilateral rotation induced by the dopamine D2 agonist quinpirole. In both cases, the coadministration of the cannabinoid agonist together with the D1 or D2 agonist induced contralateral rotation. It appears that cannabinoids may exert different effects depending on the state of the ongoing chemical activation of this brain circuitry.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8848272     DOI: 10.1016/0304-3940(96)12436-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Potential role of cannabinoids in Parkinson's disease.

Authors:  J Sevcík; K Masek
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  Development of a new mouse brain tumor model using implantable micro-cannulas.

Authors:  W Griffitt; R P Glick; T Lichtor; D E Haughton; E P Cohen
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

3.  The effects of acute treatment with delta9-THC on exploratory behaviour and memory in the rat.

Authors:  R Hernández-Tristán; C Arévalo; S Canals; M L Leret
Journal:  J Physiol Biochem       Date:  2000-03       Impact factor: 4.158

4.  Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.

Authors:  Swapnil Gupta; Joao P De Aquino; Deepak C D'Souza; Mohini Ranganathan
Journal:  Psychopharmacology (Berl)       Date:  2019-03-27       Impact factor: 4.530

5.  Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia.

Authors:  F Rodríguez De Fonseca; M A Gorriti; A Bilbao; L Escuredo; L M García-Segura; D Piomelli; M Navarro
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

6.  Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine.

Authors:  Hadi Fathi Moghaddam; Mohammad Javad Khodayar; Seyed Mohammad Zarei Abarghouei; Mehdi Shafiee Ardestani
Journal:  Saudi Pharm J       Date:  2010-05-31       Impact factor: 4.330

7.  Unbalanced Inhibitory/Excitatory Responses in the Substantia Nigra Pars Reticulata Underlie Cannabinoid-Related Slowness of Movements.

Authors:  Ana S Báez-Cordero; Ana K Pimentel-Farfan; Teresa Peña-Rangel; Pavel E Rueda-Orozco
Journal:  J Neurosci       Date:  2020-06-12       Impact factor: 6.167

8.  Bilingual Two-Way Immersion Programs Benefit Academic Achievement.

Authors:  Viorica Marian; Anthony Shook; Scott R Schroeder
Journal:  Biling Res J       Date:  2013

9.  Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor.

Authors:  M Beltramo; F R de Fonseca; M Navarro; A Calignano; M A Gorriti; G Grammatikopoulos; A G Sadile; A Giuffrida; D Piomelli
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

10.  Endocannabinoid modulation of dopaminergic motor circuits.

Authors:  Teresa Morera-Herreras; Cristina Miguelez; Asier Aristieta; José Ángel Ruiz-Ortega; Luisa Ugedo
Journal:  Front Pharmacol       Date:  2012-06-12       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.